Extracorporeally Induced Total-Body Hyperthermia for Disseminated Cancer
Although the mechanisms of the anticancer effects of hyperthermia have remained obscure, it is now generally accepted that the heating temperature must be at least 41.0°C or greater to achieve cancer regression. Clinically applied thermochemotherapy can be divided into local and total-body hyperthermia (TBHT). Local hyperthermia has been primarily used in the treatment of superficial and localized malignant tumors. Because advanced cancer infiltrates neighboring organs and is often metastatic to other distant organs, TBHT appears to be a reasonable and a promising approach. Although various methods for TBHT have been reported, we have been performed TBHT using an extracorporeal circuit modified from the original of Parks et al.2 In this chapter, we describe the clinical effect of TBHT combined with anticancer chemotherapy and some problems in this area.
KeywordsAntitumor Effect Advanced Cancer Patient Extracorporeal Circuit Local Hyperthermia Anticancer Chemotherapy
Unable to display preview. Download preview PDF.
- 2.L.C. Parks, M. Minaberry, D.P. Smith, and W.A. Neely, Treatment of far-advanced bronchogenic carcinoma by extracorporeally induced systemic hyperthermia, Thorac Cardiovasc Surg. 78: 883, (1979).Google Scholar
- 3.S.L. Warren, Preliminary study of the effect of artificial fever upon hopeless tumor cases, Am J Roentgenol 33: 75, (1935).Google Scholar
- 7.J. Euler-Rolle, A. Driesching, E. Vormittag, C. Tschakakoff, and P. Polteraner, Prevention of cardiac complications during whole-body hyperthermia by beta-receptor blockage, in: “Cancer Therapy by Hyperthermia and Radiation,” C. Streffer, ed., Urban Schwarzenberg, Baltimore (1978).Google Scholar
- 8.J.M.C. Bull, D. Lees, W. Schuette, J. Whang-Peng, R. Smith, G. Bynum, R. Atkinson, J.S. Gottdiener, H.R. Gralnick, T.H. Shawker, and V.T. DeVita, Whole-body hyperthermia: phase-1 trial of a potential adjuvant chemotherapy, Ann Intern Med. 90: 137, (1979).Google Scholar
- 10.S. Koga and M. Maeta, Total-body hyperthermia and chemotherapy, in: “Hyperthermia in Cancer Treatment,” Vol.III, L.J. Anghileri J. Robert, eds., CRC Press, Boca Raton (1986).Google Scholar
- 17.A.P. Gee, A.D. Williams, R.T. Rettigrew, and A.N. Smith, The effects of whole-body hyperthermia therapy on the general immunocompetence of the advanced cancer patient, in: “Cancer Therapy by Hyperthermia and Radiation,” C. Streffer, ed., Urban Schwarzenberg, Baltimore (1978).Google Scholar
- 19.D.A. Karnofsky, Meaningful clinical classification of the therapeutic response to anticancer drugs. Clin Pharmcol Ther. 2: 709, (1961).Google Scholar
- 22.R. Engelhardt, Whole-body hyperthermia, in: “Abstract of the 5th International Symposium on Hyperthermic Oncology”, Kyoto, Japan (1988).Google Scholar
- 25.B. Barlogie, P.M. Corry, and B. Drewindo, In vitro thermochemotherapy of human colon cancer cells with cis-dichloro-diammineplatinum (II) and mitomycin C, Cancer Res. 40:1165, (1981).Google Scholar
- 31.K. Aukland, B.F. Bower, and R.W. Berliner, Measurement of local blood flow with hydrogen gas, Circulation Res. 4: 164, (1964).Google Scholar